This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...